Dizal Reveals Promising Hematology Pipeline Developments at ASH 2025#China#Shanghai#Dizal#Golidocitinib#SSE688192
Dizal Reveals Promising Hematology Pipeline Developments at ASH 2025
Dizal Pharmaceuticals showcased new advancements in its hematology pipeline, presenting promising data on golidocitinib and birelentinib during ASH 2025.
third-news.com
December 9, 2025 at 10:13 AM
Dizal Reveals Promising Hematology Pipeline Developments at ASH 2025#China#Shanghai#Dizal#Golidocitinib#SSE688192